Skip to main navigation Skip to search Skip to main content

Public stem cell banks: Considerations of justice in stem cell research and therapy

  • Ruth R. Faden
  • , Liza Dawson
  • , Alison S. Bateman-House
  • , Dawn Mueller Agnew
  • , Hilary Bok
  • , Dan W. Brock
  • , Aravinda Chakravarti
  • , Xiao Jiang Gao
  • , Mark Greene
  • , John A. Hansen
  • , Patricia A. King
  • , Stephen J. O'Brien
  • , David H. Sachs
  • , Kathryn E. Schill
  • , Andrew Siegel
  • , Davor Solter
  • , Sonia M. Suter
  • , Catherine M. Verfaillie
  • , Leroy B. Walters
  • , John D. Gearhart

Research output: Contribution to journal › Review article › peer-review

Abstract

If stem cells fulfill their therapeutic promise, moving them from the laboratory into the clinic will raise several concerns about justice. One concern is that, for biological reasons alone, stem cell-based therapies might not be available for every patient who needs one. Worse, depending on how we address the problem of biological access, they might benefit primarily white Americans. We can avoid this outcome - although at a cost - by carefully selecting the stem cells we make available.

Original languageEnglish (US)
Pages (from-to)13-27
Number of pages15
JournalHastings Center Report
Volume33
Issue number6
DOIs
StatePublished - Nov 2003

ASJC Scopus subject areas

  • Health(social science)
  • Issues, ethics and legal aspects
  • Philosophy
  • Health Policy

Fingerprint

Dive into the research topics of 'Public stem cell banks: Considerations of justice in stem cell research and therapy'. Together they form a unique fingerprint.

Cite this